ct of liver and with cta without & with contrast enhancement shows:
techniques: 
from lower chest to liver inferior edge in 5-mm contiguous section, contrast 
medium injected at 2ml/sec, 30 sec after initiation of injection, starting 
arterial phase scan;  portal phase scan performed in 20 sec after the end of the
 arterial phase scan; and venous phase scan began in 20 sec after the end of the
 portal phase scan, reformation of images for ct angiography
findings 
lobulated contour of liver compatible with liver cirrhosis
mild splenomegaly 
huge well-defined right liver tumor about 12cm in s4-8 with early enhancement 
and washout, favor hcc
one daughter enhanced liver nodule about 3cm is noted
patency of portal veins, no evidence of portal thrombosis
patent hepatic arteries, both rha and lha from pha
patent ivc and hvs, obliterated mhv and rhv due to mass effect
no definite space occupying lesion in the pancreas and spleen 
no definite biliary dilatation, s/p cholecystectomy
normal function of both kidneys, no hydronephrosis
no definite enlargement of retroperitoneal lns  
no abnormal fluid collection in the abdomen 
volumetry of liver with right lobe of 1426cm3 and left lobe of 529m3; the spleen
 volume of 250cm3
imp:
liver cirrhosis with splenomegaly
huge well-defined enhanced right liver tumor about 12cm in s4-8 with daughter 
nodule and mass effect to hvs, favor hcc 
patent pvs, has and hvs except obliterated mhv due to mass effect 

(tentative tumor staging)
¡´imaging report form for hepatocellua carcinoma (ajcc 8th edition)
1.tumor number/location: 
number: ¡³1 ¡´2 ¡³3 multiple:
location: ¡¼ 
2.tumor size: 
    ¡³measurable: 12 cm (the largest tumor)
    ¡³non-measurable
3.tumor characteristics and associated liver features
    ¡³vascular invasion 
    ¡³extrahepatic spread 
    ¡³ascites 
    ¡³portal vein thrombosis, location 
    ¡³portosystemic collateral vessel
    ¡³typical enhancement pattern (hypervascular enhancement and early wash-out)
3.pathology: ¡´not available ¡³available (pathology type:¡¼)

-------------------primary tumor(t)--------------------------
 tx  ¡³ primary tumor cannot be assessed 
 t0  ¡³ no primary tumor 
stage i
t1   ¡³ solitary tumor ¡Ø2 cm, or > 2cm without vascular invasion
t1a  solitary tumor ¡Ø2 cm
t1b  solitary tumor > 2cm without vascular invasion
stage ii
t2   ¡³ solitary tumor >2cm with vascular invasion, or multiple tumors,none >5
cm 
stage iii
t3   ¡´multiple tumors more than 5 cm 
t4   ¡³tsingle tumor or multiple tumors of any size involving a major
branch of the portal vein or hepatic vein, or tumor(s) with direct
invasion of adjacent organs other than the gallbladder or with
perforation of visceral peritoneum 
-------------------regional lymph nodes(n)-----------------
nx   ¡³regional lymph nodes cannot be assessed 
n0   ¡´no regional lymph nodes
stage iva
n1   ¡³regional lymph node metastasis 
     ¡³periceliac, ¡³hilar( common bile duct, hepatic artery, portal vein and 
cystic duct) ¡³peripancreatic ¡³paraaortic ¡³portocaval ¡³retrocaval
¡³others_______ 
-------------------distant metastasis(m)----------------------
stage ivb
m1  ¡³distant metastasis
¡³	invasion of gallbladder
¡³	cardiophrenic, mesenteric, retrocrural ln
imaging stage  t3 n0( in this study)
